Last reviewed · How we verify
treatment of deep vein thrombosis
Approved treatments
Clinical guidelines
- FDA label — 1L
Apixaban is indicated for the treatment of DVT. - FDA label — 1L
XARELTO is indicated for the treatment of deep vein thrombosis (DVT).
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- treatment of deep vein thrombosis patent landscape — cliff calendar, originator estates, attackable patents
- treatment of deep vein thrombosis treatment landscape brief
- treatment of deep vein thrombosis treatment updates RSS
Frequently asked questions about treatment of deep vein thrombosis
What are the treatment guidelines for treatment of deep vein thrombosis?
FDA label publishes guidelines for treatment of deep vein thrombosis. 2 guideline references tracked.
Related
- Treatment landscape: treatment of deep vein thrombosis patent cliff · treatment of deep vein thrombosis CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing